Innovo Therapeutics
San Diego
About Innovo Therapeutics
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.9M
- Funding stage: Seed
- Last round: Seed (Dec 2023)
- Website: innovotherapeutics.com
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/innovo-therapeutics-84300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.